Skip to main content
. Author manuscript; available in PMC: 2014 Jul 7.
Published in final edited form as: Am J Hematol. 2012 Oct 31;88(1):56–59. doi: 10.1002/ajh.23345

Figure 2.

Figure 2

Overall survival of FLT3-mutated MDS patients versus FLT3-nonmutated CMML patients. Kaplan–Meier analysis of overall survival (OS) for FLT3-mutated MDS patients versus FLT3-nonmutated CMML petients. The OS did not differ significantly for FLT3-mutated versus FLT3-nonmutated patients. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]